Table 2.
Results summary for NRT and cancer
CAF no.a | References | Exposure | Endpoint | Casesb | Hazard ratioc (95 % CI) | Adjustments |
---|---|---|---|---|---|---|
1 | Murray et al. (2009) | Mean daily NRT use | Lung cancer | 75 | 1.02 (0.95–1.09) | d |
1.04 (0.97–1.12) | e | |||||
GI cancer | 33 | 0.97 (0.86–1.10) | d | |||
0.97 (0.82–1.14) | e | |||||
All cancer | 203 | 1.00 (0.96–1.05) | d | |||
1.01 (0.97–1.06) | e |
a CAF critical assessment form. CAF 1 is a prospective study
bDuring the 7.5-year follow-up period following the 5-year period of the Lung Health Study
cPer piece of gum used per day on average during the Lung Health Study
dBaseline age, sex, cigarettes per day and lifetime pack-years of smoking
eAlso adjusted for pack-years cigarette use over the 5-year period of the Lung Health Study